Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease
Conclusion: Exenatide plus insulin glargine treatment for 24 weeks resulted in a reduction of albuminuria in T2DM patients with DKD.Am J Nephrol
Source: American Journal of Nephrology - Category: Neurology Source Type: research
More News: Byetta | Cardiology | Cardiovascular | Clinical Trials | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Gastroenterology | Heart | Humalog | Insulin | Lantus | Neurology | Study | Urology & Nephrology